The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%.

The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%. Immunosuppression reduction is the management cornerstone for BKV and has been shown to be effective at clearing the virus while maintaining graft function in both kidney alone and simultaneous kidney-pancreas transplant recipients. However, there is a lack of published data on the prevalence and outcomes in simultaneous liver-kidney (SLK) transplant recipients.

Inclusion Criteria:

• Age 18 years or older
• SLK recipients transplanted at MDMC between 2015-2020

Exclusion Criteria:

• Below 18 years of age
• Patients who did not undergo SLK transplant at MDMC

SLK transplant recipients who were transplanted at MDMC over a 6-year period (2015 to 2020).